Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Showing posts with label oldest-old. Show all posts
Showing posts with label oldest-old. Show all posts

Tuesday, August 13, 2024

EVT on Large Core Strokes: Sobering Results for the Oldest Old

 Ask your competent? doctor EXACTLY HOW THEY ARE GOING TO GET EVERY PATIENT FULLY AMBULATORY at 90 days! NO plans? You don't have a functioning stroke doctor! Why are you seeing them?

EVT on Large Core Strokes: Sobering Results for the Oldest Old

Successful reperfusion associated with good functional outcomes(Not true according to your statistics!) regardless of age

A computer rendering of a blood clot blocking a blood vessel.

The older the patient, the worse the functional outcome tended to be after endovascular thrombectomy (EVT) for an acute ischemic stroke with a large infarct, observational data suggested.

Based on a German multicenter registry, the likelihood of independent ambulation at 90 days (modified Rankin Scale [mRS] score of 0-3) following thrombectomy dropped steadily as age increased (P<0.001):

(This is definitely a sign of doctor failure!)

  • 56.4% in patients 60 years and younger
  • 36.5% in those 61-70
  • 20.2% ages 71-80
  • 15.1% in those older than 80 years

Similarly, the risk of 90-day mortality (mRS score of 6) was increasingly unfavorable with older age (P<0.001): (This is definitely a sign of doctor failure!)

  • 15.4% at age 60 and below
  • 31.8% in those 61-70
  • 52.1% at ages 71-80
  • 64.3% for those older than 80 years

Age over 80 was confirmed to be an independent predictor of less independent ambulation (adjusted OR 0.44, 95% CI 0.23-0.82) and more mortality (adjusted OR 2.75, 95% CI 1.61-4.72) after EVT, reported a group led by Laurens Winkelmeier, MD, of University Medical Center Hamburg-Eppendorf, Germany, in JAMA Network Open.

"The association between age and functional outcomes in acute ischemic stroke [AIS] is evident. This association is mediated by higher burden of comorbidities, greater cognitive impairment, and larger frailty levels in elderly patients, among other factors," the authors wrote.

Their report adds to the scant data on stroke thrombectomy for people 80 and older, who have been underrepresented in randomized trials but are frequently encountered in real clinical practice. Current guidelines do not endorse an upper age limit to EVT.

"The question arises whether these extremely poor functional outcomes might justify the application of a fixed upper age limit for endovascular thrombectomy in acute ischemic stroke with large infarct," they suggested. "An upper age limit might simplify acute management and free up capacities of endovascular thrombectomy, but it would also underestimate the heterogeneity of aging across individuals."

The group cautioned that chronological age alone does not necessarily determine clinical outcomes. "Under specific conditions, patients older than 80 years could have a better clinical prognosis than younger patients receiving endovascular thrombectomy for large ischemic stroke," Winkelmeier and colleagues observed.

They reported that the proportion of people older than 80 with large infarcts achieving the main endpoint at 90 days ranged from 1% to 46% depending on prestroke mRS, admission NIH Stroke Scale (NIHSS) score, and final modified Thrombolysis in Cerebral Infarction (mTICI) grade.

In fact, across age groups, a predictor of independent ambulation was a final mTICI grade 2b or 3 (adjusted OR 4.95, 95% CI 2.14-11.43). Such successful reperfusion, achieved in 81.9% of people in the German registry, was also associated with lower mortality at 90 days (adjusted OR 0.23, 95% CI 0.13-0.43).

This "timely study adds to the mounting evidence indicating that swift [successful reperfusion] following EVT appears to be the strongest predictor of good clinical outcomes and improved survival in patients with large-core AIS, even in the oldest-old (>80 years) subgroup," commented Georgios Tsivgoulis, MD, of Attikon University Hospital, Athens, Greece, and Bruce Campbell, PhD, of Royal Melbourne Hospital, Australia, in an accompanying editorial.

"Given the available randomized and observational evidence, the findings ... reinforce the existing notion that EVT for AIS with large infarct should not be withheld based on an upper age limit. Nevertheless, age needs to be integrated within a multimodal prognostic approach to individualize treatment decisions in these patients with the worst prognosis in terms of AIS natural history," the duo wrote.

The retrospective cohort study was based on the German Stroke Registry that included patients with AIS due to anterior circulation large vessel occlusion and large infarct.

Winkelmeier's group identified 408 patients who received endovascular thrombectomy from 2015 to 2021 at 25 German stroke centers and met study inclusion criteria.

These patients were 53.2% women with a median age of 75 years. The median prestroke mRS was 0, indicating a group with no significant disability before admission. On admission, the median NIH Stroke Scale score was 17 points, indicating severe neurological impairment. The baseline Alberta Stroke Program Early Computed Tomography Score (ASPECTS) was 5.

Study authors reported that IV thrombolysis was administered in 35.4% of the study population.

After endovascular thrombectomy, there was a 7.0% incidence of symptomatic intracranial hemorrhage within 24 hours.(So the doctors here haven't figured out how to prevent that hemorrhage. I wouldn't go to any hospital that hasn't figured that out yet. Having figured that out is a sign of competence!)

By 90 days, patients achieved mRS 0-3 in 28.9% of cases while 44.6% had died.

Tsivgoulis and Campbell warned of the lack of propensity score matching to control for between-group imbalances in this retrospective analysis. "Age and frailty are correlated, and it is likely, given the data were derived from a registry of clinical practice, that physician judgement regarding frailty in older patients was applied such that patients who received EVT may not be fully representative of their peers," they wrote.

The editorialists also pointed out the study's exclusion of patients with tandem occlusions, the underrepresentation of people with very low ASPECTS, and lack of information on baseline ischemic core volume.

Winkelmeier and colleagues acknowledged the substantial missing mRS scores in their dataset. In addition, results may not apply outside Germany or to less developed healthcare systems, they said.

  • author['full_name']

    Nicole Lou is a reporter for MedPage Today, where she covers cardiology news and other developments in medicine. Follow

Disclosures

Winkelmeier, Tsivgoulis, and Campbell had no disclosures.

Study co-authors reported various ties to industry.

Primary Source

JAMA Network Open

Source Reference: Winkelmeier L, et al "Age and functional outcomes in patients with large ischemic stroke receiving endovascular thrombectomy" JAMA Netw Open 2024; DOI: 10.1001/jamanetworkopen.2024.26007.

Secondary Source

JAMA Network Open

Source Reference: Tsivgoulis G, Campbell BC "Endovascular thrombectomy for large core ischemic stroke -- age matters" JAMA Netw Open 2024; DOI: 10.1001/jamanetworkopen.2024.25958.

Saturday, June 17, 2023

Superior Global Cognition in Oldest-Old Is Associated with Resistance to Neurodegenerative Pathologies: Results from The 90+ Study

And what protocols does your doctors have to ensure you have superior global cognition? NOTHING? Then why are you seeing them? My Mom at 94 is still doing good with only a 6th grade education.

Take it yourself:

STANDARDIZED MINI-MENTAL STATE EXAMINATION (SMMSE)

Number 12 I still would fail at. In the hospital after three days in the ICU I failed knowing the date and day of the week and the name of the building and floor.

Superior Global Cognition in Oldest-Old Is Associated with Resistance to Neurodegenerative Pathologies: Results from The 90+ Study

Price: EUR 27.50

Tuesday, May 30, 2023

Superior cognition in individuals who are 90+ associated with resilience to neurodegenerative pathologies

 My mom who is 94, still living alone in the old house, laundry still in basement is doing pretty good yet. Still drives locally, haven't convinced her yet to get a hearing aid so repeating sentences is required.  Dad however died at 92 with Parkinson's dementia the last three years. So I'm going to live a very long time with half my life being differently abled, stroke at age 50, I'm shooting for 100+ and going to get there.

Superior cognition in individuals who are 90+ associated with resilience to neurodegenerative pathologies

A University of California, Irvine-led team of researchers have discovered that the oldest-old, those who live to be 90+ and have superior cognitive skills, have similar levels of brain pathology as Alzheimer's patients, however, they also have less brain pathology of other neurodegenerative diseases that cause memory and thinking problems.

The study, "Superior Global Cognition in Oldest-Old is Associated with Resistance to Neurodegenerative Pathologies: Results from the 90+ Study," was published in the Journal of Alzheimer's Disease.

People who are 90+ and still have good memory and thinking abilities tend to have similar levels of Alzheimer's pathology in their brains. Our findings indicate that while Alzheimer's Disease neuropathological changes and vascular changes are common in their brains, these individuals are less susceptible to other types of neurodegenerative changes such as Lewy body disease."

Roshni Biswas, post-doctoral scholar with The 90+ Study

Age is the primary risk factor for cognitive issues, such as Alzheimer's, Lewy body disease and other related dementias. Over the past 30 years, the number of people aged 90 and older in the U.S. has nearly tripled, and this number is projected to quadruple in the next four decades.

With this rise in age, many people see increased problems with memory and brain function. However, little data is available on the changes in the brains of 90+ people who maintain superior cognitive abilities, despite their age.

The objective of the study was to examine the brain features of people without cognitive impairment and their relation to superior cognitive skills and reasoning in those that are 90+.

"There are some individuals who can maintain high levels of cognitive function well into advanced ages," said María M. Corrada, ScD, co-principal investigator of the study and professor in the Department of Neurology at UCI School of Medicine. "Further research into the factors that enable these individuals to maintain their cognitive function could provide insights into how to preserve cognitive health despite advanced age."

The study results were derived by analyzing autopsy data from 102 cognitively normal individuals who died at a mean age of 97.6 years. They also used cognitive test scores from people taken between two to twelve months before death. The average age of study participants at the time of their last visit was 97.1 years of age.

"In our future research, we will examine how lifestyle habits and health conditions are associated with superior cognition in individuals who are 90+ and the factors that contribute to maintaining stable cognitive function over time," said Biswas.

The 90+ Study is a longitudinal study on aging and dementia that was initiated in 2003 to study the oldest-old population, which is the fastest growing age group in the United States.

With more than 2000 participants enrolled, it is now one of the largest studies of its kind in the world. The project has produced several significant findings regarding cognitive function, health and lifestyle habits in the oldest-old population information obtained during life.

This work was supported by the National Institutes of Health.

Source:
Journal reference:

Biswas, R., et al. (2023) Superior Global Cognition in Oldest-Old is Associated with Resistance to Neurodegenerative Pathologies: Results from the 90+ Study. Journal of Alzheimer s Disease. doi.org/10.3233/JAD-221062.